Cardiac scientists say they are being muzzled by Health NZ over an objection to changes in the way diabetes treatments are funded.
8 minutes ago
File image.
Cardiac scientists within Health NZ say they are being muzzled by their parent organisation over an objection to changes in the way diabetes treatments are funded.
According to its website, Pharmac is "proposing to change who can receive funded treatment with empagliflozin, dulaglutide and liraglutide".
"This includes widening access to these medicines by lowering the clinical threshold for heart disease risk and removing ethnicity-based eligibility criteria."
The changes would take drugs from Maori and Pasifika and give them to people who don't need them, and endocrinologist tells Nine…
Not everyone is allowed to use the new medication - even people with high BMI or diabetes
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
Eli Lilly calls on Britain’s health service to pay higher prices for medicines
New study raises urgent questions about how doctors treat diabetes
Dapagliflozin cuts heart failure hospitalisations by 80% in high-risk genetic carriers
Here's how you can TRICK your body into thinking it's on fat jabs
